DE2708827C2 - - Google Patents

Info

Publication number
DE2708827C2
DE2708827C2 DE2708827A DE2708827A DE2708827C2 DE 2708827 C2 DE2708827 C2 DE 2708827C2 DE 2708827 A DE2708827 A DE 2708827A DE 2708827 A DE2708827 A DE 2708827A DE 2708827 C2 DE2708827 C2 DE 2708827C2
Authority
DE
Germany
Prior art keywords
compound
formula
guanine
formyloxyethoxymethyl
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2708827A
Other languages
German (de)
English (en)
Other versions
DE2708827A1 (de
Inventor
Howard John Richmond Va. Us Schaeffer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB7988/76A external-priority patent/GB1561380A/en
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of DE2708827A1 publication Critical patent/DE2708827A1/de
Application granted granted Critical
Publication of DE2708827C2 publication Critical patent/DE2708827C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE19772708827 1976-03-01 1977-03-01 Substituierte purinverbindungen, verfahren zu ihrer herstellung und pharmazeutische zubereitungen Granted DE2708827A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7988/76A GB1561380A (en) 1976-03-01 1976-03-01 Esters of hydroxyalkoxyalkyl purines their preparation and pharmaceutical compositions containing them
US71810576A 1976-08-27 1976-08-27

Publications (2)

Publication Number Publication Date
DE2708827A1 DE2708827A1 (de) 1977-09-08
DE2708827C2 true DE2708827C2 (es) 1989-01-12

Family

ID=26241801

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772708827 Granted DE2708827A1 (de) 1976-03-01 1977-03-01 Substituierte purinverbindungen, verfahren zu ihrer herstellung und pharmazeutische zubereitungen

Country Status (25)

Country Link
JP (1) JPS52106896A (es)
AR (4) AR228232A1 (es)
AT (1) AT361007B (es)
AU (1) AU515553B2 (es)
BE (1) BE851972R (es)
BG (2) BG28067A3 (es)
CA (1) CA1086316A (es)
CH (4) CH629806A5 (es)
DD (1) DD128611A5 (es)
DE (1) DE2708827A1 (es)
DK (1) DK147824C (es)
ES (1) ES456432A2 (es)
FI (1) FI60710C (es)
FR (1) FR2342972A2 (es)
GR (1) GR66070B (es)
HU (1) HU176907B (es)
IE (1) IE44708B1 (es)
IT (1) IT8048953A0 (es)
LU (1) LU76869A1 (es)
NL (2) NL7702175A (es)
PL (2) PL115267B1 (es)
RO (1) RO76591A (es)
SE (1) SE433216B (es)
SU (1) SU637086A3 (es)
ZA (1) ZA771220B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8202626A (nl) * 1982-06-29 1984-01-16 Stichting Rega V Z W Derivaten van 9-(2-hydroxyethoxymethyl)guanine.
ES520140A0 (es) * 1983-02-25 1984-04-01 Ind Farma Especial Un procedimiento para la preparacion de acicloguanosina.
GB8816760D0 (en) * 1988-07-14 1988-08-17 Wellcome Found Therapeutic compounds
JP4704223B2 (ja) * 2006-01-30 2011-06-15 Ｈｏｙａ株式会社 送りねじ機構

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5122049A (ja) * 1974-08-19 1976-02-21 Sanwa Denki Kk Kahenteikosochi

Also Published As

Publication number Publication date
SE7702233L (sv) 1977-09-02
DK147824B (da) 1984-12-17
DK88677A (da) 1977-09-02
FR2342972B2 (es) 1980-06-27
FR2342972A2 (fr) 1977-09-30
PL115242B1 (en) 1981-03-31
JPS52106896A (en) 1977-09-07
FI60710B (fi) 1981-11-30
NL8400896A (nl) 1984-07-02
FI60710C (fi) 1982-03-10
SU637086A3 (ru) 1978-12-05
LU76869A1 (es) 1977-09-26
ZA771220B (en) 1978-10-25
ES456432A2 (es) 1978-07-16
CH632757A5 (en) 1982-10-29
ATA134877A (de) 1980-07-15
DE2708827A1 (de) 1977-09-08
DD128611A5 (de) 1977-11-30
AU2275977A (en) 1978-09-07
IT8048953A0 (it) 1980-06-12
GR66070B (es) 1981-01-15
JPS635392B2 (es) 1988-02-03
AR228283A1 (es) 1983-02-15
CH632758A5 (en) 1982-10-29
HU176907B (en) 1981-05-28
CH629806A5 (en) 1982-05-14
AR228282A1 (es) 1983-02-15
BE851972R (fr) 1977-09-01
IE44708B1 (en) 1982-03-10
BG28067A3 (en) 1980-02-25
IE44708L (en) 1977-09-01
PL196356A1 (pl) 1979-05-07
PL211568A1 (pl) 1979-07-30
DK147824C (da) 1985-07-22
NL7702175A (nl) 1977-09-05
FI770655A (es) 1977-09-02
SE433216B (sv) 1984-05-14
BG27750A3 (en) 1979-12-12
PL115267B1 (en) 1981-03-31
AR228232A1 (es) 1983-02-15
RO76591A (ro) 1981-04-30
AT361007B (de) 1981-02-10
CA1086316A (en) 1980-09-23
CH631176A5 (en) 1982-07-30
AU515553B2 (en) 1981-04-09
AR228281A1 (es) 1983-02-15

Similar Documents

Publication Publication Date Title
DE2539963C2 (de) Purinverbindungen, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen, welche diese Verbindungen enthalten
DE69033915T2 (de) Xanthinderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Anwendung
EP0212535B1 (de) N6-Disubstituierte Purinderivate, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
DE69419755T2 (de) Chemische verbindungen mit pde-iv inhibitierende wirkung
DE3852682T2 (de) Therapeutische Nucleoside.
DE69815554T2 (de) Purinderivate und antagonisten des adenosin-a2-rezeptors, welche zur vorsorge oder heilung von diabetes dienen
DE69132291T2 (de) Xanthinderivate
DD202717A5 (de) Antivirale purinderivate und verfahren zu ihrer herstellung
DE3687007T2 (de) 6-thioxanthinderivate.
DE3888999T2 (de) 9(2-(Hydroxymethyl)cycloalkylmethyl)-guanine.
DD203052A5 (de) Verfahren zur herstellung von 9-(1,3-dihydroxy-2-propoxy-methyl)-guanin, dessen salzen und bestimmten benzylderivaten desselben
DD274766A5 (de) Verfahren zur herstellung einer pharmazeutischen formulierung
DE2918261C2 (es)
DE2263100C2 (de) 5,5-Dimethyl-8-(3-methyl-2-octyl)-10-[4-(piperidino)-butyryloxy]-2-(2-propinyl)-1,2,3,4-tetrahydro-5H-[1]-benzopyrano[3,4-d]pyridin, Verfahren zu dessen Herstellung und die Verbindung enthaltende Arzneimittel
DE2708827C2 (es)
EP0400686A1 (de) 2-Amino-9-[1,3-bis-(isopropoxy)-propyl-2-oxymethyl]-purin, seine Verwendung und diese Verbindung enthaltende Arzneimittel
EP0122488B1 (de) Bis-(Piperazinyl- bzw. Homopiperazinyl)-Alkane
CH634844A5 (de) Verfahren zur herstellung von in 9-stellung substituierten 8-azapurinen.
CH632759A5 (de) Verfahren zur herstellung neuer substituierter purine.
DE2742708C2 (de) 8-(1H-Tetrazol-5-yl)-11H-pyrido eckige Klammer auf 2,1-b eckige Klammer zu chinazolin-11-one und Verwendung derselben bei der Bekämpfung von Bronchialasthma
EP0349928A2 (de) Purinderivate
CH632748A5 (de) Verfahren zur herstellung von uracilderivaten.
AT360043B (de) Verfahren zur herstellung von neuen 9-substi- tuierten purinen und deren salzen
AT352751B (de) Verfahren zur herstellung von neuen 9-substi- tuierten 6-hydroxypurinen und deren salzen
EP0196330B1 (de) Verwendung von pyrrothinderivaten

Legal Events

Date Code Title Description
OD Request for examination
AF Is addition to no.

Ref country code: DE

Ref document number: 2539963

Format of ref document f/p: P

AF Is addition to no.

Ref country code: DE

Ref document number: 2539963

Format of ref document f/p: P

D2 Grant after examination
8364 No opposition during term of opposition